- Home
- APLM vs QMCO Comparison
APLM vs QMCO Comparison
Compare APLM & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- QMCO
- Stock Information
- Founded
- APLM 2016
- QMCO 1980
- Country
- APLM United States
- QMCO United States
- Employees
- APLM N/A
- QMCO N/A
- Industry
- APLM Blank Checks
- QMCO Electronic Components
- Sector
- APLM Finance
- QMCO Technology
- Exchange
- APLM Nasdaq
- QMCO Nasdaq
- Market Cap
- APLM 6.1M
- QMCO 98.8M
- IPO Year
- APLM N/A
- QMCO N/A
- Fundamental
- Price
- APLM $6.83
- QMCO $7.36
- Analyst Decision
- APLM
- QMCO Hold
- Analyst Count
- APLM 0
- QMCO 2
- Target Price
- APLM N/A
- QMCO $19.00
- AVG Volume (30 Days)
- APLM 36.5K
- QMCO 636.7K
- Earning Date
- APLM 09-23-2025
- QMCO 09-10-2025
- Dividend Yield
- APLM N/A
- QMCO N/A
- EPS Growth
- APLM N/A
- QMCO N/A
- EPS
- APLM N/A
- QMCO N/A
- Revenue
- APLM $198,000.00
- QMCO $266,079,000.00
- Revenue This Year
- APLM $415.15
- QMCO $7.49
- Revenue Next Year
- APLM N/A
- QMCO $3.22
- P/E Ratio
- APLM N/A
- QMCO N/A
- Revenue Growth
- APLM N/A
- QMCO N/A
- 52 Week Low
- APLM $3.66
- QMCO $2.88
- 52 Week High
- APLM $35.98
- QMCO $90.64
- Technical
- Relative Strength Index (RSI)
- APLM 62.80
- QMCO 46.24
- Support Level
- APLM $3.66
- QMCO $7.07
- Resistance Level
- APLM $6.37
- QMCO $8.62
- Average True Range (ATR)
- APLM 0.63
- QMCO 0.42
- MACD
- APLM 0.20
- QMCO 0.07
- Stochastic Oscillator
- APLM 94.91
- QMCO 21.74
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).